Tasso, Inc.

SEATTLE, WA 98119
http://www.tassoinc.com
3 Employees

SBIR Award Summary

Total Number of Awards 9
Total Value of Awards $7.63MM
First Award Date 02/08/13
Most Recent Award Date 09/21/17

Key Personnel

Last Name Name Awards Contact
Berthier Erwin Berthier 7 Message
Casavant Ben Casavant 2 Message
CASAVANT BENJAMIN PUN CASAVANT 2

9 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-16-302
Budget: 09/21/17 - 06/30/18

Project Summary There is an urgent unmet need for simplified and improved blood testing systems that can be utilized outside of centralized clinical settings. Blood cancers are a major health problem in the United States, representing over 10% of all new cancers. Acute myeloid leukemia (AML) is a particularly fast-evolving form of cancer with lo...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: RFA-AI-14-049
Budget: 09/01/16 - 08/31/17

? DESCRIPTION (provided by applicant): There is an urgent need for diagnostic technologies that can rapidly inform a healthcare professional on the appropriate management strategy for patients with infectious diseases. Recent epidemics of flu and Ebola have crucially highlighted the importance for rapid detection solutions. However, point-of-...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-14-071
Budget: 06/09/16 - 05/31/17

? DESCRIPTION (provided by applicant): There is an urgent unmet need for diagnostic technologies that can rapidly inform a healthcare professional on the appropriate management strategy for patients with infectious diseases. Recent epidemics of flu and Ebola have crucially highlighted the importance for rapid detection solutions. However, poin...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: RFA-AI-14-049
Budget: 09/01/15 - 08/31/16

DESCRIPTION (provided by applicant): There is an urgent need for diagnostic technologies that can rapidly inform a healthcare professional on the appropriate management strategy for patients with infectious diseases. Recent epidemics of flu and Ebola have crucially highlighted the importance for rapid detection solutions. However, point-of-care ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: RFA-EB-12-001
Budget: 04/01/14 - 03/31/15

DESCRIPTION (provided by applicant): Economic, logistical, and physical barriers limit HIV viral load quantification, the gold standard for HIV diagnostics. The cost of the test is high (approximately $100 per test) and the intricate equipment required limits testing to laboratories staffed by highly trained technicians. Also, the labile nature ...

Phase 2 SBIR

Agency: Defense Advanced Research Projects Agency
Topic: SB122-003
Budget: 01/16/14 - 04/11/16

Blood-based point-of-care (POC) diagnostics or remote diagnostics that require specialized equipment only available in centralized, commercial laboratories are currently limited by major logistical and technical barriers. Blood collection can be a traumatic, inconvenient, and inconsistent process that is based on decades-old technologies, such a...

Phase 2 SBIR

Agency: Defense Advanced Research Projects Agency
Topic: SB122-003
Budget: 01/01/14 - 12/31/14

Blood-based point-of-care (POC) diagnostics or remote diagnostics that require specialized equipment only available in centralized, commercial laboratories are currently limited by major logistical and technical barriers. Blood collection can be a traumatic, inconvenient, and inconsistent process that is based on decades-old technologies, such a...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: RFA-EB-12-001
Budget: 09/24/13 - 03/31/14

DESCRIPTION (provided by applicant): Economic, logistical, and physical barriers limit HIV viral load quantification, the gold standard for HIV diagnostics. The cost of the test is high (approximately $100 per test) and the intricate equipment required limits testing to laboratories staffed by highly trained technicians. Also, the labile nature ...

Phase 1 SBIR

Agency: Defense Advanced Research Projects Agency
Topic: SB122-003
Budget: 02/08/13 - 11/16/13

Blood-based assays require upstream mechanisms to acquire sample from a patient, extract the analyte of interest, and preserve the analyte until it can be quantified. Current point-of-care assays overwhelmingly rely on lancet puncture, which is inconvenient because of the presence of blood that is open to the environment and induces high levels ...